Erin Quirk
President at TERNS PHARMACEUTICALS, INC.
Net worth: 492 000 $ as of 2024-03-30
Profile
Erin Quirk is currently the President and Head of Research & Development at Terns Pharmaceuticals, Inc. Prior to this, Dr. Quirk worked at Gilead Sciences, Inc. as the Vice President of HIV Clinical Research from 2010 to 2018.
Dr. Quirk completed their undergraduate degree at Drew University and their graduate degree at The University of Colorado.
They also obtained a doctorate degree from The University of Colorado School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-22 | 75,000 ( 0.12% ) | 492 000 $ | 2024-03-30 |
Erin Quirk active positions
| Companies | Position | Start |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | President | 2024-02-06 |
Former positions of Erin Quirk
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2018-08-31 |
Training of Erin Quirk
| Drew University | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Erin Quirk
